SCHEDULE 13G

Company

Zivo Bioscience, Inc.

Filed

September 13, 2017

Accession Number

0001078782-17-001258

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →